Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck.
about
Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Cetuximab Rechallenge and Mono ...... arcinoma of the Head and Neck.
@en
Cetuximab Rechallenge and Mono ...... arcinoma of the Head and Neck.
@nl
type
label
Cetuximab Rechallenge and Mono ...... arcinoma of the Head and Neck.
@en
Cetuximab Rechallenge and Mono ...... arcinoma of the Head and Neck.
@nl
prefLabel
Cetuximab Rechallenge and Mono ...... arcinoma of the Head and Neck.
@en
Cetuximab Rechallenge and Mono ...... arcinoma of the Head and Neck.
@nl
P2860
P356
P1476
Cetuximab Rechallenge and Mono ...... arcinoma of the Head and Neck.
@en
P2093
Greg Knutzen
Shanmuga Subbiah
P2860
P304
P356
10.1159/000441019
P577
2015-09-01T00:00:00Z